Compound dominant-null heterozygosity in a family with RP1-related retinal dystrophy. (2022)
Attributed to:
New genetic therapy approaches for inherited retinal diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ajoc.2022.101698
PubMed Identifier: 36393903
Publication URI: http://europepmc.org/abstract/MED/36393903
Type: Journal Article/Review
Volume: 28
Parent Publication: American journal of ophthalmology case reports
ISSN: 2451-9936